166 related articles for article (PubMed ID: 30994873)
21. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria.
Sato T; Ichinohe T; Kanda J; Yamashita K; Kondo T; Ishikawa T; Uchiyama T; Takaori-Kondo A
Int J Hematol; 2011 Apr; 93(4):532-541. PubMed ID: 21465116
[TBL] [Abstract][Full Text] [Related]
22. Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures.
Bassim CW; Fassil H; Mays JW; Edwards D; Baird K; Steinberg SM; Williams KM; Cowen EW; Mitchell SA; Cole K; Taylor T; Avila D; Zhang D; Pulanic D; Grkovic L; Fowler D; Gress RE; Pavletic SZ
Bone Marrow Transplant; 2014 Jan; 49(1):116-21. PubMed ID: 23995099
[TBL] [Abstract][Full Text] [Related]
23. Verification of the new grading scale for ocular chronic graft-versus-host disease developed by the German-Austrian-Swiss consensus conference on chronic GVHD.
Blecha C; Wolff D; Holler B; Holler E; Weber D; Vogt R; Helbig H; Dietrich-Ntoukas T
Ann Hematol; 2016 Feb; 95(3):493-9. PubMed ID: 26659079
[TBL] [Abstract][Full Text] [Related]
24. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease.
Hillen U; Häusermann P; Massi D; Janin A; Wolff D; Lawitschka A; Greinix H; Meyer R; Ziemer M
J Eur Acad Dermatol Venereol; 2015 May; 29(5):948-54. PubMed ID: 25265987
[TBL] [Abstract][Full Text] [Related]
25. Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population.
Vasconcellos de Souza C; Vigorito AC; Miranda ECM; Garcia C; Rensi Colturato VA; Mauad MA; Rodrigues Moreira MC; da Silva Bouzas LF; Lermontov S; Hamerschlak N; Rodrigues M; Carlos de Almeida Barros J; Chiattone R; Lee SJ; Flowers MED
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1313-1318. PubMed ID: 27058616
[TBL] [Abstract][Full Text] [Related]
26. Grading criteria for chronic ocular graft-versus-host disease: comparing the NIH eye score, Japanese dry eye score, and DEWS 2007 score.
Tatematsu Y; Ogawa Y; Abe T; Kamoi M; Uchino M; Saijo-Ban Y; Yaguchi S; Mukai S; Mori T; Okamoto S; Tsubota K
Sci Rep; 2014 Oct; 4():6680. PubMed ID: 25338290
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous Chronic Graft Versus Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation in Children: A Retrospective Study.
Shreberk-Hassidim R; Neumark M; Greenberger S; Goldstein G; Hassidim A; Dukler Y; Maly A; Stepensky P; Molho-Pessach V
Acta Derm Venereol; 2018 Feb; 98(2):206-211. PubMed ID: 29057425
[TBL] [Abstract][Full Text] [Related]
28. Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
Lertkovit O; Anurathapan U; Hongeng S; Thokanit NS; Pakakasama S
Int J Hematol; 2021 Apr; 113(4):556-565. PubMed ID: 33385291
[TBL] [Abstract][Full Text] [Related]
29. Ocular Chronic Graft-versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes after Allogeneic Hematopoietic Cell Transplantation.
Jeppesen H; Gjærde LK; Lindegaard J; Julian HO; Heegaard S; Sengeløv H
Transplant Cell Ther; 2022 Dec; 28(12):833.e1-833.e7. PubMed ID: 36002105
[TBL] [Abstract][Full Text] [Related]
30. Late follow-up of genital and ophthalmologic chronic graft-vs-host disease in females after allogeneic stem cell transplantation.
Smith Knutsson E; Nicklasson M; Björk Y; Stenberg K; Sundfeldt K; Brune M
Acta Obstet Gynecol Scand; 2022 Mar; 101(3):364-373. PubMed ID: 34962288
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice.
Greinix HT; Loddenkemper C; Pavletic SZ; Holler E; Socié G; Lawitschka A; Halter J; Wolff D
Biol Blood Marrow Transplant; 2011 Feb; 17(2):167-75. PubMed ID: 20691801
[TBL] [Abstract][Full Text] [Related]
32. Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review.
Weisdorf DJ; Hurd D; Carter S; Howe C; Jensen LA; Wagner J; Stablein D; Thompson J; Kernan NA
Biol Blood Marrow Transplant; 2003 Aug; 9(8):512-8. PubMed ID: 12931120
[TBL] [Abstract][Full Text] [Related]
33. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
Front Immunol; 2019; 10():1879. PubMed ID: 31507582
[TBL] [Abstract][Full Text] [Related]
34. Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity.
Jachiet M; de Masson A; Peffault de Latour R; Rybojad M; Robin M; Bourhis JH; Xhaard A; Dhedin N; Sicre de Fontbrune F; Suarez F; Barete S; Parquet N; Nguyen S; Ades L; Rubio MT; Wittnebel S; Bagot M; Socié G; Bouaziz JD
Br J Dermatol; 2014 Jul; 171(1):63-8. PubMed ID: 24404963
[TBL] [Abstract][Full Text] [Related]
35. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
[TBL] [Abstract][Full Text] [Related]
36. Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium.
Treister N; Chai X; Kurland B; Pavletic S; Weisdorf D; Pidala J; Palmer J; Martin P; Inamoto Y; Arora M; Flowers M; Jacobsohn D; Jagasia M; Arai S; Lee SJ; Cutler C
Bone Marrow Transplant; 2013 Aug; 48(8):1123-8. PubMed ID: 23353804
[TBL] [Abstract][Full Text] [Related]
37. Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients.
Mueller SM; Haeusermann P; Rovó A; Halter JP; Passweg J; Itin P; Tichelli A
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1574-80. PubMed ID: 23962394
[TBL] [Abstract][Full Text] [Related]
38. Assessment of joint and fascia manifestations in chronic graft-versus-host disease.
Inamoto Y; Pidala J; Chai X; Kurland BF; Weisdorf D; Flowers ME; Palmer J; Arai S; Jacobsohn D; Cutler C; Jagasia M; Goldberg JD; Martin PJ; Pavletic SZ; Vogelsang GB; Lee SJ; Carpenter PA;
Arthritis Rheumatol; 2014 Apr; 66(4):1044-52. PubMed ID: 24757155
[TBL] [Abstract][Full Text] [Related]
39. Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.
Rosenbach M; Yeung H; Chu EY; Kim EJ; Payne AS; Takeshita J; Vittorio CC; Wanat KA; Werth VP; Gelfand JM
JAMA Dermatol; 2013 May; 149(5):550-6. PubMed ID: 23677081
[TBL] [Abstract][Full Text] [Related]
40. Real-Time Reflectance Confocal Microscopy of Cutaneous Graft-versus-Host Disease Correlates with Histopathology.
Reingold RE; Monnier J; Ardigò M; Stoll JR; Pena MC; Nanda JK; Dusza SW; Ruiz JD; Flynn L; Afrin A; Klein EG; Prockop SE; Pulitzer MP; Ponce DM; Markova A; Jain M
Transplant Cell Ther; 2022 Jan; 28(1):51.e1-51.e14. PubMed ID: 34571213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
